Quotes 5-day view Delayed Nyse
10/19/2020
10/20/2020
10/21/2020
10/22/2020
10/23/2020
Date
108.04(c)
108.36(c)
105.93(c)
109.48(c)
107.79(c)
Last
4 228 515
3 873 504
5 716 007
4 954 280
3 395 508
Volume
-1.49% +0.30% -2.24% +3.35% -1.54% Change
Sales 2020
33 885 M - -
Net income 2020
4 415 M - -
Net Debt 2020
11 438 M - -
P/E ratio 2020
44,7x
Yield 2020
1,32%
Sales 2021
38 229 M - -
Net income 2021
5 807 M - -
Net Debt 2021
8 390 M - -
P/E ratio 2021
34,8x
Yield 2021
1,45%
Capitalization
194 B 194 B -
EV / Sales 2020
6,06x
EV / Sales 2021
5,29x
Nbr of Employees
107 000
Free-Float
88,8%
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the...
Notations Surperformance© of Abbott Laboratories
Trading Rating : Investor Rating :
All news about ABBOTT LABORATORIES
News in other languages on ABBOTT LABORATORIES
Analyst Recommendations on ABBOTT LABORATORIES
Roche diagnostics business surges as COVID-19 infections rise
Chart ABBOTT LABORATORIES
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ABBOTT LABORATORIES
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
23
Average target price
117,78 $
Last Close Price
109,48 $
Spread / Highest target
18,7%
Spread / Average Target
7,58%
Spread / Lowest Target
-25,1%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
